Pneumococcal Diseases Require Constant Vaccine Development | NCPA 2025

As Streptococcus pneumoniae (S. pneumoniae)bacteria evolves over time, vaccine development is forced to follow suit in order to keep patients protected against pneumococcal diseases and their shifting serotypes, according to a session presented at the National Community Pharmacists Association (NCPA) 2025 Annual Convention & Expo.¹

In her presentation, Jeannie Grubbs, PharmD, manager at Publix Pharmacy, discussed the “shifting epidemiology” of pneumococcal vaccines for adults. She provided the pharmacist audience with insights on available pneumococcal vaccines, recommendations for specific adult populations, and general trends of pneumococcal…